[HTML][HTML] Discovery of pancreatic adenocarcinoma biomarkers by untargeted metabolomics

A Martín-Blázquez, C Jiménez-Luna, C Díaz… - Cancers, 2020 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection …

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.

A Martín-Blázquez, C Jiménez-Luna, C Díaz… - Cancers, 2020 - folia.unifr.ch
English Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection …

[HTML][HTML] Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

A Martín-Blázquez, C Jiménez-Luna, C Díaz… - Cancers, 2020 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection …

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.

A Martín-Blázquez, C Jiménez-Luna, C Díaz… - Cancers, 2020 - sonar.ch
English Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection …

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

A Martín-Blázquez, C Jiménez-Luna, C Díaz… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection …

[引用][C] Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

A Martin-Blazquez, C Jimenez-Luna, C Diaz… - Cancers (Web …, 2020 - jglobal.jst.go.jp
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics | Article
Information | J-GLOBAL Art J-GLOBAL ID:202102227658155259 Reference number:21A0803875 …

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

A Martín-Blázquez, C Jiménez-Luna, C Díaz… - …, 2020 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection …

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.

A Martín-Blázquez, C Jiménez-Luna, C Díaz… - …, 2020 - search.ebscohost.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection …

[PDF][PDF] Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

A Martín-Blázquez, C Jiménez-Luna, C Díaz… - pdfs.semanticscholar.org
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection …

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

A Martín Blázquez, C Jiménez Luna, C Díaz… - 2020 - digibug.ugr.es
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection …